Clinical Research Directory

Radiocaine Safety Study In Healthy Human Subjects

Sponsor: Lutroo Imaging LLC

Summary

This is a Phase 1, single-center, open-label study evaluating the safety, biodistribution, and radiation dosimetry of Radiocaine™, an investigational fluorine-18-labeled PET radiotracer designed to bind voltage-gated sodium channels in pain-related peripheral nerves. The study will enroll healthy adult volunteers and aims to inform future clinical development in pain imaging. Radiocaine™ is being developed as a potential imaging biomarker for the localization and quantification of pain.

Official title: [18F]Radiocaine: Radiation and Radiochemical Safety

Key Details

Conditions

Interventions

Locations (1)